Oliver Lomas - Concepedia

Author

Oliver Lomas

Also Known As

Lomas, Oliver, O Lomas, O. C. Lomas, O. Lomas, OLIVER LOMAS, Oliver C Lomas, Oliver C. Lomas, Oliver Christopher Lomas, Oliver Lomas

Publications

853

Citations

H-Index

Concepts

All Affiliations

University of Oxford University College London University College London Hospitals NHS Foundation Trust University Hospital Southampton NHS Foundation Trust Oxford University Hospitals NHS Trust

About

Oliver Lomas is an author at University of Oxford specializing in medicine, signal transduction, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	174
2	Health Sciences	2	2	73
3	Cell Biology	2	2	101
4	Public Health	1	1	87
5	Biomedical Engineering	1	1	14

Oliver Lomas

Publications

487

Citations

H-Index

Page 1

	Year	Citations
Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase Svetlana Reilly, Xing Liu, Ricardo Carnicer, Science Translational Medicine Cardiac MuscleHeart FailureLong Non-coding RnaPublic HealthCell Signaling	2016	87
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study Lennard Y. W. Lee, Maria C. Ionescu, Thomas Starkey, European Journal of Cancer	2022	63
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration Kenneth C. Anderson, Daniel Auclair, Stacey J. Adam, Clinical Cancer Research Mixed-phenotype Acute LeukemiaPathologyClinical CareMyeloid NeoplasiaHematological Malignancy	2021	62
Intracellular tortuosity underlies slow cAMP diffusion in adult ventricular myocytes Mark Richards, Oliver Lomas, Kees Jalink, Cardiovascular Research	2016	57
Oxidation of Protein Kinase A Regulatory Subunit PKARIα Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release Jillian N. Simon, Besarte Vrellaku, Stefania Monterisi, Circulation	2020	38
Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation Nicolas Lellouche, F. Sacher, Matthew Wright, EP Europace	2009	36
The management of Castleman disease Oliver Lomas, Matthew Streetly, Guy Pratt, British Journal of Haematology	2021	27
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis Alexandros Rampotas, Matthew R. Wilson, Oliver Lomas, British Journal of Haematology	2021	21
Phase 1b Study of Menin-KMT2A Inhibitor Bleximenib in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with <i>KMT2Ar</i> or <i>NPM1</i> Alterations Christian Récher, Jenny O’Nions, Ibrahim Aldoss, Blood	2024	21
A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP) Thomas Starkey, Maria C. Ionescu, Michaël Tilby, Scientific Reports	2023	20

Page 1